Episode

Fake Peptides, Eli Lilly's Breakthrough & The S&P Split | GCP 1007

Podcast: Group Chat
Published: May 26, 2026
Duration seconds: 4442
Processing state: not_requested
Canonical source: https://groupchat.libsyn.com/fake-peptides-eli-lillys-breakthrough-the-sp-split-gcp-1007
Audio: https://traffic.libsyn.com/secure/groupchat/GCP_1007_PODCAST_mixdown.mp3?dest-id=2184830
JSON: /v1/public/podcasts/group-chat-1064096/episodes/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007
Markdown: /podcast/group-chat-1064096/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007.md

Actions

POST https://stenobird.com/v1/public/podcasts/group-chat-1064096/episodes/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/group-chat-1064096/fake-peptides-eli-lilly-s-breakthrough-the-s-p-split-gcp-1007.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Group Chat News is back with the hottest stories of the week. We get into fake peptides showing up in pools and locker rooms, Eli Lilly's gene therapy IV that drops cholesterol 65% for 18 months, and the wild gap between an S&P at all-time highs and consumer sentiment at all-time lows. We dig into the AI optimist vs. pessimist split, Andrew Sorkin's 1929 doomer pitch on 60 Minutes, and why the next Carnegies need to start building parks and libraries to win back public sentiment,the American fitness test, and much more